Last updated on June 2016

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major Surgery


Brief description of study

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major Surgery

Detailed Study Description

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, evaluation of the safety of N1539 in adult subjects undergoing major surgery.

Clinical Study Identifier: TX144131

Contact Investigators or Research Sites near you

Start Over

Rachel Karlnoski

University of South Florida - South Tampa Center for Advanced Healthcare
Tampa, FL USA
  Connect »